Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to comptothecins in vitro using non-substrate drugs or the VCRP inhibitor GF120918

M. Maliepaard; M.A. van Gastelen; A. Tohgo; J.H. Beijnen; J.H.M. Schellens

Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to comptothecins in vitro using non-substrate drugs or the VCRP inhibitor GF120918

M. Maliepaard
, M.A. van Gastelen
, A. Tohgo
, J.H. Beijnen
, J.H.M. Schellens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	935-941
Number of pages	7
Journal	Clinical Cancer Research
Volume	7
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{50f2443bf16846f79103d26559c4d06f,

title = "Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to comptothecins in vitro using non-substrate drugs or the VCRP inhibitor GF120918",

author = "M. Maliepaard and \{van Gastelen\}, M.A. and A. Tohgo and J.H. Beijnen and J.H.M. Schellens",

year = "2001",

language = "Undefined/Unknown",

volume = "7",

pages = "935--941",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to comptothecins in vitro using non-substrate drugs or the VCRP inhibitor GF120918

AU - Maliepaard, M.

AU - van Gastelen, M.A.

AU - Tohgo, A.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2001

Y1 - 2001

M3 - Article

SN - 1078-0432

VL - 7

SP - 935

EP - 941

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -